148 related articles for article (PubMed ID: 19620401)
1. Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells.
Allan LL; Hoefl K; Zheng DJ; Chung BK; Kozak FK; Tan R; van den Elzen P
Blood; 2009 Sep; 114(12):2411-6. PubMed ID: 19620401
[TBL] [Abstract][Full Text] [Related]
2. Scavenger receptors target glycolipids for natural killer T cell activation.
Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
[TBL] [Abstract][Full Text] [Related]
3. NKT-cell help to B lymphocytes can occur independently of cognate interaction.
Tonti E; Galli G; Malzone C; Abrignani S; Casorati G; Dellabona P
Blood; 2009 Jan; 113(2):370-6. PubMed ID: 18832653
[TBL] [Abstract][Full Text] [Related]
4. NKT and tolerance.
Diana J; Beaudoin L; Gautron AS; Lehuen A
Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
[TBL] [Abstract][Full Text] [Related]
5. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
6. CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling.
Allan LL; Stax AM; Zheng DJ; Chung BK; Kozak FK; Tan R; van den Elzen P
J Immunol; 2011 May; 186(9):5261-72. PubMed ID: 21451111
[TBL] [Abstract][Full Text] [Related]
7. Autoreactivity to Sulfatide by Human Invariant NKT Cells.
Stax AM; Tuengel J; Girardi E; Kitano N; Allan LL; Liu V; Zheng D; Panenka WJ; Guillaume J; Wong CH; van Calenbergh S; Zajonc DM; van den Elzen P
J Immunol; 2017 Jul; 199(1):97-106. PubMed ID: 28526683
[TBL] [Abstract][Full Text] [Related]
8. Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.
Schneiders FL; Huijts CM; Mantici A; Menks MA; Scotet E; Veerhuis R; Verheul HM; de Gruijl TD; van der Vliet HJ
Clin Immunol; 2015 May; 158(1):92-9. PubMed ID: 25796193
[TBL] [Abstract][Full Text] [Related]
9. Efficient activation of Valpha14 invariant NKT cells by foreign lipid antigen is associated with concurrent dendritic cell-specific self recognition.
Cheng L; Ueno A; Cho S; Im JS; Golby S; Hou S; Porcelli SA; Yang Y
J Immunol; 2007 Mar; 178(5):2755-62. PubMed ID: 17312118
[TBL] [Abstract][Full Text] [Related]
10. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
[TBL] [Abstract][Full Text] [Related]
11. Acidification-dependent activation of CD1d-restricted natural killer T cells is intact in cystic fibrosis.
Rzemieniak SE; Hirschfeld AF; Victor RE; Chilvers MA; Zheng D; van den Elzen P; Turvey SE
Immunology; 2010 Jun; 130(2):288-95. PubMed ID: 20102408
[TBL] [Abstract][Full Text] [Related]
12. Analyzing Antigen Recognition by Natural Killer T Cells.
Zeissig S; Blumberg RS
Methods Mol Biol; 2019; 1988():439-453. PubMed ID: 31147957
[TBL] [Abstract][Full Text] [Related]
13. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
14. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
15. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and cellular site of glycolipid loading control the outcome of natural killer T cell activation.
Im JS; Arora P; Bricard G; Molano A; Venkataswamy MM; Baine I; Jerud ES; Goldberg MF; Baena A; Yu KO; Ndonye RM; Howell AR; Yuan W; Cresswell P; Chang YT; Illarionov PA; Besra GS; Porcelli SA
Immunity; 2009 Jun; 30(6):888-98. PubMed ID: 19538930
[TBL] [Abstract][Full Text] [Related]
17. Ox-LDL-induced CD80
Wang Y; Zou Y; Jiang Q; Li W; Chai X; Zhao T; Liu S; Yuan Z; Yu C; Wang T
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1563-C1572. PubMed ID: 38586879
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
[TBL] [Abstract][Full Text] [Related]
19. Unappreciated diversity within the pool of CD1d-restricted T cells.
Pellicci DG; Uldrich AP
Semin Cell Dev Biol; 2018 Dec; 84():42-47. PubMed ID: 29183709
[TBL] [Abstract][Full Text] [Related]
20. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Galli G; Nuti S; Tavarini S; Galli-Stampino L; De Lalla C; Casorati G; Dellabona P; Abrignani S
J Exp Med; 2003 Apr; 197(8):1051-7. PubMed ID: 12695492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
